Finance

Lists
ERF:EPA
Eurofins Scientific SE
€69.68
+1.25%
(+0.86) 1D
Aug 5, 5:35:14 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ERF...
Open
€68.78
High
€69.86
Low
€68.74
Mkt. cap
12.19B
Avg. vol.
253.84K
Volume
137.60K
P/E ratio
25.92
52-wk high
€74.32
52-wk low
€54.86
EPS
€2.69
Shares outstanding
176.00M
No. of employees
65K
Open
€68.78
High
€69.86
Low
€68.74
Mkt. cap
12.19B
Avg. vol.
253.84K
Volume
137.60K
P/E ratio
25.92
52-wk high
€74.32
52-wk low
€54.86
EPS
€2.69
Shares outstanding
176.00M
No. of employees
65K
News stories
From sources across the web
Profile
Eurofins Scientific SE is a French group of laboratories headquartered in Luxembourg, providing testing and support services to the pharmaceutical, food, environmental, agriscience and consumer products industries and to governments. Eurofins Group has an international network of over 900 laboratories in 62 countries and a portfolio of over 200,000 validated analytical methods for characterizing the safety, identity, purity, composition, authenticity and origin of products and biological substances. Eurofins also provides clinical diagnostic testing services and in-vitro diagnostic products. Wikipedia
About Eurofins Scientific SE
CEOGilles G. Martin
Employees65K
Founded1987
Headquarters-
SectorHealth care
Last report
Jul 23, 2026
Fiscal period
Q2 2026
EPS / Est. (EUR)
- / -
Revenue / Est. (EUR)
1.85B / 1.93B
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.84B
1.84B
1.85B
1.85B
Cost of goods sold
1.43B
1.43B
1.41B
1.41B
Cost of revenue
1.43B
1.43B
1.41B
1.41B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.05M
1.05M
-
-
Operating expense
171.20M
171.20M
139.35M
139.35M
Total operating expenses
1.60B
1.60B
1.55B
1.55B
Operating income
244.15M
244.15M
299.20M
299.20M
Other non operating income
1.85M
1.85M
4.10M
4.10M
EBT including unusual items
153.90M
153.90M
209.65M
209.65M
EBT excluding unusual items
206.70M
206.70M
260.00M
260.00M
Income tax expense
40.70M
40.70M
58.80M
58.80M
Effective tax rate
26.45%
26.45%
28.05%
28.05%
Other operating expenses
-
-
-
-
Net income
114.10M
114.10M
150.70M
150.70M
Net profit margin
6.19%
6.19%
8.14%
8.14%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-41.55M
-41.55M
-42.85M
-42.85M
Net interest expenses
-41.55M
-41.55M
-42.85M
-42.85M
Depreciation and amortization charges
141.40M
141.40M
135.40M
135.40M
EBITDA
318.85M
318.85M
457.60M
457.60M
Gain or loss from assets sale
3.30M
3.30M
950.00K
950.00K
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps